Tmax in three treatment, three period, three sequence design [Nonparametrics]

posted by libaiyi – China, 2019-04-09 09:15 (1638 d 10:01 ago) – Posting: # 20134
Views: 2,697

Dear all,

I have a question about Wilcoxon signed rank test on Tmax. In a three treatment, three period, three sequece design (two test formulations and one reference formulation with the sequences as T1-R-T2, R-T2-T1, and T2-T1-R), can we use Wilcoxon signed rank test for Tmax? If not, what can we do to statistically evaluate Tmax?

Thanks in advance!



Complete thread:

UA Flag
 Admin contact
22,770 posts in 4,777 threads, 1,627 registered users;
20 visitors (0 registered, 20 guests [including 6 identified bots]).
Forum time: 19:16 CEST (Europe/Vienna)

The real struggle is not between the right and the left
but between the party of the thoughtful
and the party of the jerks.    Jimmy Wales

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz